Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 2—February 2024
Letter

Nonnegligible Seroprevalence and Predictors of Murine Typhus, Japan

On This Page
Article Metrics

Cite This Article

To the Editor: I was impressed by the recent publication by Aita et al. who reported a surprisingly high seroprevalence rate for Rickettsia typhi within resident populations on Honshu Island, Japan (1). The authors pointed out the possibility of murine typhus reemergence in Japan, where the disease has been reported only sporadically (2). However, the conclusions might be premature because the study was cross-sectional, and only 1 timepoint was evaluated. Many cases of murine typhus could have occurred in the distant past, which might not be reflected in this type of study. A previous study in Spain showed a high incidence rate in patients who were much younger (mean age of ≈46 years) (3) than those reported in this study (mean age of 67 years). A study in Greece showed frequent epidemiologic links to flea exposure (4), but the study in Japan did not investigate this apparent risk factor. I do not believe that age-related differences in flea exposures exist in Japan; hence, it is likely that exposures might have occurred in the past, when persons in Japan had a lower standard of hygiene. According to another study, the median half-life of R. typhi IgG was 177 days, and the median IgG titer was 800 at day 365 postinfection, suggesting long-lasting seropositivity (5). Therefore, the relatively stringent cutoff value of R. typhi serology in this study (1) could have overestimated the prevalence. To demonstrate that murine typhus is indeed a reemerging disease in Japan, further actual cases in Japan need to be identified, or similar seroprevalence studies should be repeated in other regions to determine trends in R. typhi seropositivity.

Top

Kentaro IwataComments to Author 
Author affiliation: Kobe University Hospital, Kobe, Japan

Top

References

  1. Aita  T, Sando  E, Katoh  S, Hamaguchi  S, Fujita  H, Kurita  N. Nonnegligible seroprevalence and predictors of murine typhus, Japan. Emerg Infect Dis. 2023;29:143842. DOIPubMedGoogle Scholar
  2. Sakaguchi  S, Sato  I, Muguruma  H, Kawano  H, Kusuhara  Y, Yano  S, et al. Reemerging murine typhus, Japan. Emerg Infect Dis. 2004;10:9645. DOIPubMedGoogle Scholar
  3. Rodríguez-Alonso  B, Almeida  H, Alonso-Sardón  M, Velasco-Tirado  V, Robaina Bordón  JM, Carranza Rodríguez  C, et al. Murine typhus. How does it affect us in the 21st century? The epidemiology of inpatients in Spain (1997-2015). Int J Infect Dis. 2020;96:16571. DOIPubMedGoogle Scholar
  4. Labropoulou  S, Charvalos  E, Chatzipanagiotou  S, Ioannidis  A, Sylignakis  P, Τaka  S, et al. Sunbathing, a possible risk factor of murine typhus infection in Greece. PLoS Negl Trop Dis. 2021;15:e0009186. DOIPubMedGoogle Scholar
  5. Phakhounthong  K, Mukaka  M, Dittrich  S, Tanganuchitcharnchai  A, Day  NPJ, White  LJ, et al. The temporal dynamics of humoral immunity to Rickettsia typhi infection in murine typhus patients. Clin Microbiol Infect. 2020;26:781.e916. DOIPubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid3002.230827

Original Publication Date: January 17, 2024

Related Links

Top

Table of Contents – Volume 30, Number 2—February 2024

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Kentaro Iwata, Professor of Infectious Diseases Therapeutics, Kobe University Hospital, Kusunokicho 7-5-2, Chuoku Kobe, Hyogo 6500017, Japan

Send To

10000 character(s) remaining.

Top

Page created: December 17, 2023
Page updated: January 24, 2024
Page reviewed: January 24, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external